P2B-057

Sarcoma Oncology Center (Santa Monica, CA) › P2B-057

P2B-057

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
Sarcoma Oncology Center (Santa Monica, CA) · Dr. Reyes
consented 2012-12-05

completed

AEs

2

Serious

0

Dropout signal

–

Adverse events

2

Grade 2 stomatitis with onset in cycle 2 (2013-01-18); assessed as related to study drug (probable); resolved 2013-01-29.

moderate assessed

Grade 1 vomiting with onset in cycle 1 (2012-12-23); assessed as not related to study drug (not related); resolved 2012-12-25.

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.